Pages that link to "Q810254"
Jump to navigation
Jump to search
The following pages link to disease-modifying antirheumatic drug (Q810254):
Displaying 50 items.
- azathioprine (Q18939) (← links)
- non-steroidal anti-inflammatory drug (Q188724) (← links)
- leflunomide (Q248550) (← links)
- adalimumab (Q348260) (← links)
- cyclosporine (Q367700) (← links)
- methyl salicylate (Q407669) (← links)
- oxaceprol (Q408948) (← links)
- rituximab (Q412323) (← links)
- infliximab (Q415264) (← links)
- etanercept (Q415343) (← links)
- levamisole (Q417097) (← links)
- glatiramer acetate (Q418274) (← links)
- sulfasalazine (Q420035) (← links)
- hydroxychloroquine (Q421094) (← links)
- auranofin (Q421230) (← links)
- D-penicillamine (Q421239) (← links)
- methotrexate (Q422232) (← links)
- chloroquine (Q422438) (← links)
- abatacept (Q2697833) (← links)
- aurotioprol (Q3629883) (← links)
- aurothioglucose (Q4072449) (← links)
- actarit (Q4676759) (← links)
- mavrilimumab (Q6794291) (← links)
- sinomenine (Q7524904) (← links)
- Category:Antirheumatic products (Q8256482) (← links)
- (Q11854271) (← links)
- antigout agent (Q17173047) (← links)
- Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis (Q21134808) (← links)
- Interleukin-6: a new therapeutic target (Q21195659) (← links)
- Molecular action of methotrexate in inflammatory diseases (Q24534771) (← links)
- Biologics, cardiovascular effects and cancer (Q24568196) (← links)
- Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification? (Q24816905) (← links)
- rifamycin (Q26270990) (← links)
- Secukinumab for rheumatology: development and its potential place in therapy (Q26738523) (← links)
- Biosimilars in rheumatology: understanding the rigor of their development (Q26744773) (← links)
- Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis (Q26750562) (← links)
- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis (Q26751187) (← links)
- Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease (Q26753120) (← links)
- Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies (Q26764867) (← links)
- The specialist physician's approach to rheumatoid arthritis in South Africa (Q26765122) (← links)
- Current concepts in the management of rheumatoid arthritis (Q26765124) (← links)
- Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration (Q26769021) (← links)
- On the predictive utility of animal models of osteoarthritis (Q26781301) (← links)
- Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis (Q26799036) (← links)
- Whipple's disease diagnosed during anti-tumor necrosis factor alpha treatment: two case reports and review of the literature (Q26799217) (← links)
- Access to an optimal treatment. Current situation (Q26799304) (← links)
- Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now? (Q26800154) (← links)
- Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint? (Q26824294) (← links)
- Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis (Q26825588) (← links)
- Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis (Q26828622) (← links)